| Daratumumab, carfilzomib, lenalidomide, and dexamethasone with minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma LJ Costa, S Chhabra, E Medvedova, BR Dholaria, TM Schmidt, KN Godby, ... Journal of Clinical Oncology 40 (25), 2901-2912, 2022 | 217 | 2022 |
| Low birth weight at term and its determinants in a tertiary hospital of Nepal: a case-control study SR Sharma, S Giri, U Timalsina, SS Bhandari, B Basyal, K Wagle, ... PloS one 10 (4), e0123962, 2015 | 199 | 2015 |
| Sarcopenia in the older adult with cancer GR Williams, RF Dunne, S Giri, SS Shachar, BJ Caan Journal of Clinical Oncology 39 (19), 2068, 2021 | 176 | 2021 |
| The spectrum of genetic mutations in breast cancer A Sheikh, SA Hussain, Q Ghori, N Naeem, A Fazil, S Giri, B Sathian, ... Asian Pacific Journal of Cancer Prevention 16 (6), 2177-2185, 2015 | 126 | 2015 |
| RS3PE revisited: a systematic review and meta-analysis of 331 cases P Karmacharya, AA Donato, MR Aryal, S Ghimire, R Pathak, K Shah, ... Clin Exp Rheumatol 34 (3), 404-15, 2016 | 119 | 2016 |
| Rituximab-induced serum sickness: a systematic review P Karmacharya, DR Poudel, R Pathak, AA Donato, S Ghimire, S Giri, ... Seminars in arthritis and rheumatism 45 (3), 334-340, 2015 | 118 | 2015 |
| Evaluation of daratumumab for the treatment of multiple myeloma in patients with high-risk cytogenetic factors: a systematic review and meta-analysis S Giri, A Grimshaw, S Bal, K Godby, P Kharel, B Djulbegovic, ... JAMA oncology 6 (11), 1759-1765, 2020 | 98 | 2020 |
| Left atrial appendage aneurysm: a systematic review of 82 cases MR Aryal, FA Hakim, S Ghimire, S Ghimire, S Giri, A Pandit, Y Bhandari, ... Echocardiography 31 (10), 1312-1318, 2014 | 96 | 2014 |
| Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review … JP Bewersdorf, S Giri, R Wang, RT Williams, MS Tallman, AM Zeidan, ... Haematologica 105 (11), 2659, 2020 | 92 | 2020 |
| Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial LJ Costa, S Chhabra, E Medvedova, BR Dholaria, TM Schmidt, KN Godby, ... The Lancet Haematology 10 (11), e890-e901, 2023 | 86 | 2023 |
| Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States AM Zeidan, R Wang, X Wang, RM Shallis, NA Podoltsev, JP Bewersdorf, ... Blood advances 4 (10), 2192-2201, 2020 | 81 | 2020 |
| Early mortality and overall survival of acute myeloid leukemia based on facility type VR Bhatt, V Shostrom, S Giri, K Gundabolu, KM Monirul Islam, ... American journal of hematology 92 (8), 764-771, 2017 | 81 | 2017 |
| Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study S Giri, R Pathak, MR Aryal, P Karmacharya, VR Bhatt, MG Martin Blood, The Journal of the American Society of Hematology 125 (21), 3359-3360, 2015 | 76 | 2015 |
| Eculizumab in transplant-associated thrombotic microangiopathy P Dhakal, S Giri, R Pathak, VR Bhatt Clinical and Applied Thrombosis/Hemostasis 23 (2), 175-180, 2017 | 74 | 2017 |
| Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review SJ Grant, AA Grimshaw, J Silberstein, D Murdaugh, TM Wildes, AE Rosko, ... Transplantation and cellular therapy 28 (6), 294-302, 2022 | 63 | 2022 |
| Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis JP Bewersdorf, S Giri, R Wang, N Podoltsev, RT Williams, MS Tallman, ... Leukemia 35 (6), 1643-1660, 2021 | 58 | 2021 |
| Review of reported causes of device embolization following trans-catheter aortic valve implantation UN Ibebuogu, S Giri, O Bolorunduro, P Tartara, S Kar, D Holmes, O Alli The American journal of cardiology 115 (12), 1767-1772, 2015 | 58 | 2015 |
| Shorter (≤ 6 months) versus longer (≥ 12 months) duration dual antiplatelet therapy after drug eluting stents: A meta‐analysis of randomized clinical trials A Pandit, S Giri, FA Hakim, FD Fortuin Catheterization and Cardiovascular Interventions 85 (1), 34-40, 2015 | 58 | 2015 |
| Quality of life among people living with acquired immune deficiency syndrome receiving anti-retroviral therapy: a study from Nepal S Giri, M Neupane, S Pant, U Timalsina, S Koirala, S Timalsina, S Sharma HIV/AIDS-Research and Palliative Care, 277-282, 2013 | 57 | 2013 |
| Right atrial appendage aneurysm: a systematic review MR Aryal, FA Hakim, S Giri, S Ghimire, A Pandit, Y Bhandari, YP Acharya, ... Echocardiography 31 (4), 534-539, 2014 | 54 | 2014 |